Emergence of an S gene mutant during thymosin α1 therapy in a patient with chronic hepatitis B

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 866-869

  Tang, Jui Hsiang ^b   Yeh, Chau Ting ^a   Chen, Tse Ching ^b   Hsieh, Sen Yung ^b   Chu, Chia Ming ^b   Liaw, Yun Fan ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; THYMOSIN ALPHA1;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGENICITY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; THERAPY RESISTANCE; VIRUS GENE; VIRUS MUTATION;

EID: 0031660024     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515345     Document Type: Article

References (15)

1. Thomas HC. The emergence of envelope and precore/core variants of hepatitis B virus: the potential role of antibody selection. J Hepatol 1995; 22:1-8.
2. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336:325-9.
3. Iwarson S, Tabor E, Thomas HC, et al. Neutralisation of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. J Med Virol 1985; 16:89-95.
4. Wallace LA, Carman WF. Surface gene variation of HBV: scientific and medical relevance. Viral Hepatitis 1997; 3:5-16.
5. McMahon G, Ehrlich PH, Moustafa ZA, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15:757-66.
6. Okamoto H, Imai M, Tsuda F, Tanake T, Miyakawa Y, Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987; 61:3030-4.
7. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 1995; 21:273-8.
8. Chen YCJ, Delbrook K, Dealwis C, Mimms L, Mushahwar IK, Mandecki W. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci USA 1996; 93: 1997-2001.
9. Günther S, Meisel H, Reip A, Miska S, Krüger DH, Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen-positive carriers who seroconvert to anti-HBe during interferon treatment. Virology 1992; 187:271-9.
10. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714-7.
11. Yeh CT, Liaw YF, Ou JH. The arginine-rich domain of hepatitis B virus precore and core protein contains a signal for nuclear transport. J Virol 1990; 64:6141-7.
12. Yeh CT, Lu SC, Chu CM, Liaw YF. Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. J Gen Virol 1997; 78:2761-70.
13. Yeh CT, Shyu WC, Sheen IS, Chu CM, Liaw YF. Quantitative assessment of hepatitis C virus RNA by polymerase chain reaction and a digoxigenin detection system: comparison with branched DNA assay. J Virol Methods 1997; 65:219-26.
14. 1 versus interferon-α in patients with hepatitis B e antigen antibody and hepatitis B virus DNA-positive chronic hepatitis B. Hepatology 1996; 24:774-7.
15. Eichberg JW, Seeff LB, Lawlor DL, et al. Effect of thymosin immunostimulation with and without corticosteroid immunosuppression on chimpanzee hepatitis B carriers. J Med Virol 1987; 21:25-37.